These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1907440)

  • 1. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
    Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
    Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
    Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
    Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
    Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
    J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
    Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
    Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
    Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
    Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of acute coronary syndromes].
    Ogawa H
    J Cardiol; 1999 Mar; 33 Suppl 1():9-16. PubMed ID: 10342131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
    Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
    Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
    Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
    Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries.
    Verheugt FW; ten Cate JW; Sturk A; Imandt L; Verhorst PM; van Eenige MJ; Verwey W; Roos JP
    Am J Cardiol; 1987 May; 59(12):1075-9. PubMed ID: 3107367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation and fibrinolysis in arteriosclerosis].
    Hoffmeister HM; Heller W; Seipel L
    Z Kardiol; 1999 May; 88(5):315-23. PubMed ID: 10413853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.
    Sakata K; Hoshino T; Yoshida H; Ono N; Ohtani S; Yokoyama S; Mori N; Kaburagi T; Kurata C; Urano T
    Am Heart J; 1992 Oct; 124(4):854-60. PubMed ID: 1529901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired fibrinolysis in coronary artery disease.
    Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
    Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
    Mehta J; Mehta P; Lawson D; Saldeen T
    J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma plasminogen activator inhibitor activity after coronary spasm.
    Misumi I; Ogawa H; Masuda T; Sakamoto T; Okumura K; Yasue H
    Int J Cardiol; 1993 Aug; 41(1):21-9. PubMed ID: 8225669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome].
    Yan J; Huang Z; Liu R; Li L; Han C; Yang J
    Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):817-20. PubMed ID: 11798724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo.
    Krishnamurti C; Alving BM
    Semin Thromb Hemost; 1992 Jan; 18(1):67-80. PubMed ID: 1374195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.